InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.91
(
0.54%
)
Bitcoin
60,289.00
(
-2.80%
)
Post# of 252476
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: biocqr post# 220642

Tuesday, 08/28/2018 3:04:56 PM

Tuesday, August 28, 2018 3:04:56 PM

Post# of 252476
FGEN has another pipeline HIF-1 drug that would be better suited to post-MI treatment. In that context you want to upregulate VEGF, for example. But they haven't talked about it in years. Some of that is a general decision to publish less and some is simply a focus on their two late-stage drugs.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up